Also known as: Inactivated polio vaccine (IPV), Salk vaccine or IPV
- DTap Hib
- DTaP only
- 2 months (no earlier than 6 weeks)
- 4 months
- 6 - 18 months
- 4 - 6 years
- People who have had severe allergic reactions after receiving this vaccine
- People who have had severe allergic reactions to the antibiotics streptomycin, polymyxin B, or neomycin
- Women who are breastfeeding
- Children with diarrhea
- Anyone who:
- Has minor upper respiratory illness, with or without fever
- Has had mild to moderate local reactions to a previous dose of vaccine
- Is taking antimicrobial therapy
- Is getting better after having an acute illness
- You are uncertain whether polio immunization should be given, particularly if there are conditions where immunization may need to be delayed or not given
- An allergic reaction or other symptoms develop after polio immunization
- You have other questions or concerns about polio immunization
Polio immunization protects against poliomyelitis, a severe disease that leads to the loss of movement.
The vaccine contains an inactive (dead) form of the polio virus. It is called an inactivated polio vaccine, or IPV. It cannot cause polio.
The IPV is available alone, or combined with:
Polio vaccination is one of the recommended childhood immunizations and vaccination should begin during infancy. In most parts of the United States, polio immunization is required before a child can start school.
WHO SHOULD RECEIVE THIS VACCINE:
Children should receive four doses of the IPV; one dose each at each of the following ages:
Children who have received three doses of the IPV before age 4 should receive a fourth dose before or at the time they first start school. The fourth dose is not needed if the third dose is given after age 4.
Adults are not given a booster polio shot unless they are likely to be in places where the disease is known to occur.
The following people should not receive IPV:
No side effects have been reported in pregnant women who have received the vaccine. However, the vaccine should be avoided during pregnancy, if possible. Pregnant woman who are at increased risk for infection and who need immediate protection should receive an IPV according to the recommended schedule for adults.
IPV can be given safely to the following people:
People who are moderately or severely ill should usually wait until they have recovered before receiving the vaccine.
The development of the polio vaccine by Dr. Jonas Salk in 1955 has helped significantly reduce the rates of polio. However, the disease remains common in some developing countries, so there is a risk that it can spread to the United States.
For almost everyone, the benefits of vaccination far outweigh the risks.
IPV may cause mild soreness and redness at the site of the injection. This is usually not severe and lasts only a few days. There are usually no other symptoms and no other care is needed after immunization.
CALL YOUR HEALTH CARE PROVIDER IF:
Centers for Disease Control and Prevention. 2011 immunization schedules for children 0 to 18 years of age. October 28, 2010.
Centers for Disease Control and Prevention. Recommended adult immunization schedule United States, 2011 Proposed Revisions, Advisory Committee on Immunization Practices. October 28, 2010.
- Review date:
- December 15, 2010
- Reviewed by:
- David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc., and Neil K. Kaneshiro, MD, MHA, Clinical Assistant Professor of Pediatrics, University of Washington School of Medicine.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2008 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.